Ekso Bionics Holdings Inc (FRA:23E2)
€ 0.58 0.012 (2.11%) Market Cap: 12.76 Mil Enterprise Value: 10.89 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 59/100

Q4 2023 Ekso Bionics Holdings Inc Earnings Call Transcript

Mar 04, 2024 / 09:30PM GMT
Release Date Price: €1.79 (+2.76%)
Operator

Greetings, and welcome to the XL bionics Fourth Quarter 2023 financial results conference call. At this time, all participants are in a listen only mode. A brief question-and-answer session will follow a formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Matt Steinberg, Finn parks Thank you. You may be.

Matt Steinberg
Lazar FINN Partners - IR

Thank you, operator, and thank you all for participating in today's call. Joining me from Ekso Bionics are Scott Davis, Chief Executive Officer, Jerome Wong, Chief Financial Officer, and Jason Jones, Chief Operating Officer.

Earlier today, Ekso Bionics released financial results for the quarter and year ended December 31, 2023. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot